Ketone Supplementation in Eating Disorders (NCT05507008) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Ketone Supplementation in Eating Disorders
United States40 participantsStarted 2022-10-13
Plain-language summary
This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on electroencephalogram (EEG) measurement. All subjects enrolled in the study will undergo EEG on two consecutive days at the beginning of the study, after active ketone supplementation or placebo drink, matched in taste to the ketone drink. Days will be randomized. Thereafter, all subjects will take the ketone supplementation drink for two weeks, twice daily.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Must currently meet DSM-5 criteria for Anorexia Nervosa, Bulimia Nervosa, or OSFED Anorexia or Bulimia Nervosa based on the MINI diagnostic interview
✓. Be medically stable as assessed by a comprehensive medical and behavioral evaluation conducted by a study physician
✓. English as primary spoken language.
✓. Ability to respond to EMA questions up to 6x per day within 60 minutes of receiving the message.
✕. Indication of intellectual disability or autism spectrum disorder
✕. Known allergy to any of the KenetikR drink components: D-beta-hydroxybutyric acid (D-BHB), Stevia, Monkfruit, Potassium Bicarbonate, Sodium Bicarbonate Potassium Sorbate or Taste Task Solutions: Sucrose, Potassium Chloride, Sodium bicarbonate.